Asthma and Allergy Foundation Approves of Drug-Tracking Bill - Beckley, Bluefield & Lewisburg News, Weather, Sports

Asthma and Allergy Foundation Approves of Drug-Tracking Bill

Posted: Updated:
WASHINGTON, D.C. -

In a press release issued Monday, the Asthma and Allergy Foundation of America (AAFA), an independent, not-for-profit health agency, expressed approval for the measures laid out in a new drug-tracking bill that passed the West Virginia Legislature Saturday.

The bill in question focuses on controlling and monitoring sales of over the counter medicines containing pseudoephedrine, which is used in the production of illegal methamphetamine.

Under the new law, West Virginia residents would not be allowed to purchase more than 3.6 grams of such medicine in one day, 7.2 grams per month and 48 grams annually. It also paves the way for West Virginia to participate in a multistate tracking program for these sales.

"The multi-state system will help to reduce illegal methamphetamine production in West Virginia without placing overly burdensome restrictions on law-abiding patients seeking relief from allergy, cold, cough and flu symptoms," said AAFA President and CEO Bill McLin.

Early in the legislative session, several elected officials called for tighter restrictions on medicines containing pseudoephedrine, some even calling for such medications to be available only with a prescription.